CF Acquisition Corp. IV (CFIV) is a Blank Checks company listed on NASDAQ. There were no new wire items for CFIV in the last 30 days. The most recent was published Feb 14, 2024.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
- 13D/GSEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
- SECSEC Form 15-12G filed by CF Acquisition Corp. IV15-12G - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form 25-NSE filed by CF Acquisition Corp. IV25-NSE - CF ACQUISITION CORP. IV (0001825249) (Subject)
- SECCF Acquisition Corp. IV filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- NEWSCF Acquisition Corp. IV Announces Its Intention To Liquidate; Wll Not Make Next $150,000 Monthly Installment Due By Nov. 28 to Its Trust Account; Will Cease All Operations Except For Purpose Of winding Up; Redeem Public Shares; Dissolve And Liquidate
- PRCF Acquisition Corp. IV Announces its Intention to LiquidateNEW YORK, Nov. 28, 2023 /PRNewswire/ -- CF Acquisition Corp. IV (NASDAQ:CFIV) ("CF IV"), a publicly traded special purpose acquisition company, today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock, par value $0.0001 per share ("Class A common stock"), sold in its initial public offering (the "public shares") because CF IV is unlikely to be able to complete an initial business combination by the deadline under its Amended and Restated Certificate of Incorporation, as amended. Accordingly, CF IV
- SECSEC Form 10-Q filed by CF Acquisition Corp. IV10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
- NEWSWhy Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving PremarketGainers Senti Biosciences, Inc. (NASDAQ:SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Tharimmune, Inc. (NASDAQ:THAR) shares rose 76.8% to $0.2790 in pre-market trading as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104. TransMedics Group, Inc. (NASDAQ:TMDX) shares rose 39.7% to $56.16 in pre-market trading after the company reported better-than-expected third-quarter sales results and issued strong FY23 r
- SECCF Acquisition Corp. IV filed SEC Form 8-K: Leadership Update8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form 10-Q filed by CF Acquisition Corp. IV10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECCF Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form DEFA14A filed by CF Acquisition Corp. IVDEFA14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
- INSIDERSEC Form 4 filed by Cfac Holdings Iv, Llc4 - CF ACQUISITION CORP. IV (0001825249) (Issuer)
- SECCF Acquisition Corp. IV filed SEC Form 8-K: Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- 13D/GSEC Form SC 13G/A filed by CF Acquisition Corp. IV (Amendment)SC 13G/A - CF ACQUISITION CORP. IV (0001825249) (Subject)
- PRCF Acquisition Corp. IV Announces That its Trust Account Will Not Be Decreased Due to Excise TaxNEW YORK, June 7, 2023 /PRNewswire/ -- CF Acquisition Corp. IV (NASDAQ: CFIV) (the "Company") today announced that, to mitigate the current uncertainty surrounding the implementation of the Inflation Reduction Act of 2022, in the event that the extension (the "Extension") of the time period the Company has to complete an initial business combination (the "Business Combination") is implemented, as described in the proxy statement filed by the Company on May 22, 2023 (the "Proxy Statement"), in connection with its special meeting of stockholders to be held on June 22, 2023 (the "Meeting"), CFAC Holdings IV, LLC (the "Sponsor"), the sponsor of the Company, or a designee, will indemnify the Comp
- SECSEC Form DEF 14A filed by CF Acquisition Corp. IVDEF 14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form 10-Q filed by CF Acquisition Corp. IV10-Q - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form PRE 14A filed by CF Acquisition Corp. IVPRE 14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form 10-K filed by CF Acquisition Corp. IV10-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- 13D/GSEC Form SC 13G filed by CF Acquisition Corp. IVSC 13G - CF ACQUISITION CORP. IV (0001825249) (Subject)
- 13D/GSEC Form SC 13G filed by CF Acquisition Corp. IVSC 13G - CF ACQUISITION CORP. IV (0001825249) (Subject)
- SECCF Acquisition Corp. IV filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - CF ACQUISITION CORP. IV (0001825249) (Filer)
- SECSEC Form DEFA14A filed by CF Acquisition Corp. IVDEFA14A - CF ACQUISITION CORP. IV (0001825249) (Filer)
CFIV FAQ
7 questionsWhat does CF Acquisition Corp. IV do?
CF Acquisition Corp. IV does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate, technology, and software industries. The company was incorporated in 2020 and is based in New York, New York.What is the latest news on CFIV?
Quantisnow has not tracked any new filings, ratings or press releases for CFIV in the last 30 days. The most recent wire item was published on February 14, 2024.Where does CFIV stock trade?
CF Acquisition Corp. IV (CFIV) is listed on NASDAQ.What sector and industry is CFIV in?
CF Acquisition Corp. IV operates in the Finance sector, Blank Checks industry.When did CF Acquisition Corp. IV go public?
CF Acquisition Corp. IV (CFIV) completed its IPO in 2021.What companies are similar to CFIV?
Notable peers in the same industry include TACO (Berto Acquisition Corp.), PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), ILLU (Illumination Acquisition Corp I), INV (Innventure Inc.). Compare CFIV side-by-side with any of them on Quantisnow.How can I track CFIV on Quantisnow?
Quantisnow aggregates CF Acquisition Corp. IV's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CFIV to receive live email and push alerts on every new disclosure.